TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ALXO

Alx Oncology Holdings 

Healthcare · Biotechnology

1.20$ -6.2% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ALXO
Line item 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
91.4% 91.9% 100.0% 96.5% 88.4% 77.8% 90.9% 85.9%
74.0% 84.5% 99.6% 95.7% 15.9% 9.2% 11.9% 27.7%
74.0% 84.5% 99.6% 95.7% 86.9% 75.3% 86.5% 75.9%
8.3% 5.0% – – 0.3% 0.4% 0.6% 0.5%
– – – – -5.8% – – –
8.6% 8.1% 0.0% 0.2% 1.3% – – –
18.0% 102.6% 1.4% 4.5% 14.0% 21.8% 23.1% 56.0%
16.8% 46.7% 1.4% 4.0% 9.2% 14.8% 12.5% 41.6%
– – – 0.2% 0.3% 0.6% 1.6% 8.8%
6.2% 35.1% 0.0% 1.0% 2.6% 3.5% 3.0% 8.3%
– 50.8% – – 3.1% 4.0% 6.4% 7.7%
82.0% -2.6% 98.6% 95.5% 86.0% 78.2% 76.9% 44.0%
-479.6% -681.7% -27.2% -53.1% -106.2% -200.5% -420.3% -1,224.2%
196.6% 205.6% 9.1% 10.6% 13.3% 17.7% 35.3% 90.9%

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?